Pharma

ABL Bio Collaborates with Merck to Develop ABL103 Plus Keytruda for Treating Solid Tumors

ABL Bio Collaborates with Merck to Develop ABL103 Plus Keytruda for Treating Solid Tumors

Shots: ABL Bio has signed a clinical trial collaboration and supply agreement with...

Prime Medicine and BMS Join Forces to Develop and Commercialize Various Prime Edited Ex Vivo T-Cell Therapies

Prime Medicine and BMS Join Forces to Develop and Commercialize Various Prime Edited Ex Vivo T-Cell Therapies

Shots: Prime Medicine & BMS have entered into a strategic research collaborati...

Orion and Aitia Join Forces for AI-Based Drug Discovery and Drug Simulation in Oncology

Orion and Aitia Join Forces for AI-Based Drug Discovery and Drug Simulation in Oncology

Shots: Orion Corporation and Aitia have entered into a partnership to develop Gemi...

Generate:Biomedicines Partners with Novartis for the Discovery of Protein Therapeutics in Various Indications

Generate:Biomedicines Partners with Novartis for the Discovery of Protein Therapeutics in Various Indications

Shots: Generate:Biomedicines has signed a multi-target collaboration with Novartis...

BioAtla Join Forces with Context Therapeutics to Develop and Commercialize BA3362 for Cancer Treatment

BioAtla Join Forces with Context Therapeutics to Develop and Commercialize BA3362 for Cancer Treatment

Shots: BioAtla & Context have signed an exclusive global licensing agreement t...

PharmaJet Join Forces with Scancell to Develop and Commercialize Needle-free DNA Vaccine for Advanced Melanoma

PharmaJet Join Forces with Scancell to Develop and Commercialize Needle-free DNA Vaccine for Advanced Melanoma

Shots: PharmaJet and Scancell have signed a long-term license and supply agreement...

Image